Another new drug for type 2 diabetes, called Prandin (repaglinide)

February 1998

You'll soon see another new drug for type 2 diabetes, called Prandin (repaglinide).

It's the first of a new class...the meglitinides.

Prandin is given before meals to reduce postprandial hyperglycemia. It stimulates the pancreas to release more insulin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

How to reduce GI bleeding and ulcers in patients taking NSAIDs
Arthrotec, the new combination of diclofenac and misoprostol
Antibiotics Trovan (trovafloxacin), a very broad-spectrum quinolone
Antibiotics Two new antibiotic EAR drops will soon hit the market
Women's Health How much estrogen is enough to prevent bone loss?
Infectious Diseases New strain that's NOT in the current vaccine
Infectious Diseases New recommendations for immunizing health care workers
Withdrawal symptoms when patients stop taking Effexor or Effexor XR (venlafaxine)
Excedrin Migraine, the first OTC approved specifically for migraines
Pediatrics Rocephin is now officially approved for acute otitis media
Diabetes Mexitil (mexiletine) for persistent diabetic neuropathy
Diabetes Another new drug for type 2 diabetes, called Prandin (repaglinide)
Diabetes Chromium for diabetes
Dermatology Regranex gel, a new biotech drug for diabetic foot ulcers
Dermatology Bactroban now comes as a CREAM
Coenzyme Q-10 (Co Q-10)
STIs New STD treatment guidelines